Insider Title Company Date Price Return Shares Value
Rubinstein Linda M Chief Financial Officer Adverum Biotechnologies, Inc. (ADVM) 2023-06-07 $14.55 -53.1% 10,000 $145,490
Return Profit / (loss) Cost
Total -53.1% $-77,290 $145,490